Showing results (21-30 of 127) with videos related to
Sort By:
Pageof 13
Haematologica|September 2, 2004
Treatment of heparin-induced thrombocytopenia with fondaparinuxJob Harenberg, Ingrid Jörg, Tivadar FenyvesiThrombosis and Haemostasis|November 6, 2009
Detection and neutralisation of heparin by a fluorescent ruthenium compoundHelga Szelke, Job Harenberg, Roland KrämerClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 11, 2022
Patients' Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test StripsJob Harenberg, Svetlana Hetjens, Christel WeissThe Israel Medical Association Journal : IMAJ|December 20, 2002
Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatranJob Harenberg, Jörg Ingrid, Fenyvesi TivadarEuropean Journal of Clinical Pharmacology|January 18, 2006
Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatranJob Harenberg, Ingrid Jörg, Christel WeissCurrent Pharmaceutical Design|April 14, 2004
Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfateBenito Casu, Marco Guerrini, Giangiacomo TorriMatrix Biology : Journal of the International Society for Matrix Biology|April 27, 2010
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancerBenito Casu, Annamaria Naggi, Giangiacomo TorriSeminars in Thrombosis and Hemostasis|September 24, 2002
Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycansBenito Casu, Annamaria Naggi, Giangiacomo TorriBiochimie|May 27, 2003
1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding siteMaurice Petitou, Benito Casu, Ulf LindahlCarbohydrate Research|August 5, 2014
Re-visiting the structure of heparinBenito Casu, Annamaria Naggi, Giangiacomo TorriPageof 13